Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low-and middle-income countries

被引:24
作者
Luz, Alia [1 ]
Santatiwongchai, Benjarin [1 ]
Pattanaphesaj, Juntana [1 ]
Teerawattananon, Yot [1 ]
机构
[1] Minist Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
来源
HEALTH RESEARCH POLICY AND SYSTEMS | 2018年 / 16卷
基金
比尔及梅琳达.盖茨基金会;
关键词
COST-EFFECTIVENESS; QUALITY; STATE; HIV;
D O I
10.1186/s12961-018-0280-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The use of economic evaluation in healthcare policies and decision-making, which is limited in low-and middle-income countries (LMICs), might be promoted through the improvement of the conduct and reporting of studies. Although the literature indicates that there are many issues affecting the conduct, reporting and use of this evidence, it is unclear which factors should be prioritised in finding solutions. This study aims to identify the top priority issues that impede the conduct, reporting and use of economic evaluation as well as potential solutions as an input for future research topics by the international Decision Support Initiative and other movements. Methods: A survey on issues regarding the conduct, reporting and use of economic evaluation as well as on potential solutions was conducted using an online questionnaire among researchers who have experience in conducting economic evaluations in LMICs. The respondents were requested to consider the list of issues provided, rank the most important ones and propose solutions. A scoring system was applied to derive the ranking of difficulties according to researchers' responses. Issues were grouped into technical and context-specific difficulties and analysed separately as a whole and by region. Results: Researchers considered the lack of quality local clinical data, poor reporting and insufficient data to conduct the analysis from the chosen perspective as the most important technical difficulties. On the other hand, the non-integration of economic evaluations into decision-making was considered the most important context-specific issue. Finally, context-specific issues were considered the larger barrier to the use of economic evaluation. Conclusion: The technical issues that were considered most important were closely linked with the lack of an appropriately functioning information system as well as the capacity to generate essential contextual information (e.g. data and locally relevant utility values), especially when the methodology is complex. To overcome this, simpler approaches to collect data that yields information of comparable quality to more rigorous methods should be developed. The international community can play a major role through research on methodologies feasible for LMIC settings as well as in building research capacity in countries. Context-specific issues, which were recognised as larger barriers, should be improved in parallel.
引用
收藏
页数:12
相关论文
共 37 条
[1]   State of health economic evaluation research in Saudi Arabia: a review [J].
Al-Aqeel, Sinaa A. .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 :177-184
[2]   HIV and Metabolic, Body, and Bone Disorders: What We Know From Low- and Middle-Income Countries [J].
Ali, Mohammed K. ;
Magee, Matthew J. ;
Dave, Joel A. ;
Ofotokun, Igho ;
Tungsiripat, Marisa ;
Jones, Trammell K. ;
Levitt, Naomi S. ;
Rimland, David ;
Armstrong, Wendy S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 :S27-S39
[3]   Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region [J].
Augustovski, Federico ;
Iglesias, Cynthia ;
Manca, Andrea ;
Drummond, Michael ;
Rubinstein, Adolfo ;
Garcia Marti, Sebastian .
PHARMACOECONOMICS, 2009, 27 (11) :919-929
[4]   What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability? [J].
Barbieri, Marco ;
Drummond, Michael ;
Rutten, Frans ;
Cook, John ;
Glick, Henry A. ;
Lis, Joanna ;
Reed, Shelby D. ;
Sculpher, Mark ;
Severens, Johan L. .
VALUE IN HEALTH, 2010, 13 (08) :1028-1037
[5]  
Batt K, 2004, B WORLD HEALTH ORGAN, V82, P689
[6]  
Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187
[7]   Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries [J].
Deogaonkar, Rohan ;
Hutubessy, Raymond ;
van der Putten, Inge ;
Evers, Silvia ;
Jit, Mark .
BMC PUBLIC HEALTH, 2012, 12
[8]   Assessing the Quality of Pharmacoeconomic Studies in India A Systematic Review [J].
Desai, Pooja R. ;
Chandwani, Hitesh S. ;
Rascati, Karen L. .
PHARMACOECONOMICS, 2012, 30 (09) :749-762
[9]  
Drummond M, 2005, MED CARE, V43, P5
[10]  
Drummond MF., 2015, METHODS EC EVALUATIO